{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T00:23:09Z","timestamp":1794183789745,"version":"4.8.0"},"update-to":[{"DOI":"10.1002\/14651858.cd000525.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000}}],"reference-count":91,"publisher":"Wiley","issue":"9","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd000525.pub4","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T10:30:48Z","timestamp":1790245848000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Zuclopenthixol acetate for acute schizophrenia and similar major mental illnesses"],"prefix":"10.1002","volume":"2026","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5896-8538","authenticated-orcid":false,"given":"Kaushadh","family":"Jayakody","sequence":"additional","affiliation":[{"name":"The Institute for Mental and Physical Health and Clinical Translation (IMPACT), School of Medicine; Deakin University; Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Chuang","sequence":"additional","affiliation":[{"name":"School of Rural Health; Monash University; Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalmini","family":"Gunadasa","sequence":"additional","affiliation":[{"name":"Department of Education; Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger Carl","family":"Gibson","sequence":"additional","affiliation":[{"name":"Department of Community Health and Psychiatry; The University of the West Indies; Kingston Jamaica"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajit","family":"Kumar","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Nursing and Health Sciences; Monash University; Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Tune","sequence":"additional","affiliation":[{"name":"School of Rural Health; Monash University; Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"key":"10.1002\/14651858.CD000525.pub4-BIB0001|cit1","unstructured":"World Health Organization Schizophrenia https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/schizophrenia"},{"issue":"9","key":"10.1002\/14651858.CD000525.pub4-BIB0002|cit2","first-page":"e254768","article-title":"Results of the Global Burden of Disease study for schizophrenia: trends from 1990 to 2021 and projections to 2050","volume":"6","author":"Zhan","year":"2025","journal-title":"Frontiers in Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD000525.pub4-BIB0003|cit3","first-page":"638","article-title":"Schizophrenia: Overview and Treatment Options","volume":"39","year":"2014","journal-title":"Pharmacy and Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD000525.pub4-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1002\/pcn5.13","article-title":"The pharmacological treatment of schizophrenia: How far have we come?","volume":"1","author":"Rubio","year":"2022","journal-title":"Psychiatry and Clinical Neurosciences Reports"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1600-0447.1993.tb03329.x","article-title":"A controlled Nordic multicentre study of zuclopenthixol acetate in oil solution, haloperidol and zuclopenthixol in the treatment of acute psychosis","volume":"87","author":"Baastrup","year":"1993","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0006|cit6","unstructured":"Professional information\/package insert clopixol acuphase\u00ae injection; October 2018 Available at https:\/\/www.lundbeck.com\/content\/dam\/lundbeck-com\/africa\/south-africa\/products\/product-pi\/Clopixol%20Acuphase%20Injection%2050%20mg-ml.pdf"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0007|cit7","volume-title":"Product monograph. Clopixol: Clopixol-acuphase: clopixol depot. antipsychotic agent","year":"2011"},{"issue":"2","key":"10.1002\/14651858.CD000525.pub4-BIB0008|cit8","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001164","article-title":"Zuclopenthixol decanoate for schizophrenia and other serious mental illnesses","author":"Coutinho","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1136\/bmj.314.7096.1740","article-title":"ABC of mental health: mental health emergencies","volume":"314","author":"Atakan","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0010|cit10","first-page":"591","article-title":"Prevalence and characteristics of violent patients in a general hospital","volume":"90","author":"Travin","year":"1990","journal-title":"New York State Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD000525.pub4-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00179201","article-title":"Serum concentrations and clinical effect of zuclopenthixol in acutely disturbed, psychotic patients treated with zuclopenthixol acetate in Viscoleo","volume":"90","author":"Amdisen","year":"1986","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1600-0447.1987.tb02759.x","article-title":"Zuclopenthixol acetate in Viscoleo \u2013 a new drug formulation. An open Nordic multicentre study of zuclopenthixol acetate in Viscoleo in patients with acute psychoses including mania and exacerbation of chronic psychoses","volume":"75","author":"Amdisen","year":"1987","journal-title":"Acta Psychiatrica Scandinavia"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1055\/s-2007-1014609","article-title":"Clinical and pharmacokinetic evaluation of zuclopenthixol acetate in Viscoleo","volume":"22","author":"Balant","year":"1989","journal-title":"Pharmacopsychiatry"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1185\/03007999009111492","article-title":"Zuclopenthixol acetate (5% in 'Viscoleo'): single-dose treatment for acutely disturbed psychotic patients","volume":"12","author":"Chakravarti","year":"1990","journal-title":"Current Medical Research and Opinion"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0015|cit15","first-page":"380","article-title":"Acute psychotic disorders treated with 5% zuclopenthixol acetate in 'Viscoleo' ('Cisordinol-Acutard'), a global assessment of the clinical effect: an open multi-centre study","volume":"5","author":"Lowert","year":"1989","journal-title":"Pharmatherapeutica"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0016|cit16","first-page":"215","article-title":"Open clinical study of Clopixol-Acuphase (zuclopenthixol acetate) treatment followed by Clopixol Depot in acute psychoses with long-term course tendency","volume":"29","author":"Predescu","year":"1991","journal-title":"Revue Roumaine de Neurologie et Psychiatrie"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0017|cit17","first-page":"280","article-title":"Efficacy of zuclopenthixol acetate on psychotic anxiety evaluated in an open study","volume":"22","author":"Romain","year":"1996","journal-title":"Encephale"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0018|cit18","first-page":"60","article-title":"Zuclopenthixol acetate in viscoleo in acutely disturbed psychotic patients","volume":"28","author":"Schlosberg","year":"1991","journal-title":"Israel Journal of Psychiatry and Related Sciences"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/00007691-199304000-00007","article-title":"Clinical evaluation and serum concentration of zuclopenthixol acetate in psychotic Asian patients: a single-dose preliminary study","volume":"15","author":"Tan","year":"1993","journal-title":"Therapuetic Drug Monitoring"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0020|cit20","unstructured":"Abdullahi AT Gadd EM Treating acute psychiatric illness at home Royal College of Psychiatrists Summer Meeting, Scarborough 1993"},{"issue":"3","key":"10.1002\/14651858.CD000525.pub4-BIB0021|cit21","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000525.pub2","article-title":"Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses","author":"Gibson","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD000525.pub4-BIB0022|cit22","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000525.pub3","article-title":"Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses","author":"Jayakody","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/13651500310000906","article-title":"Zuclopenthixol acetate versus haloperidol: An observational randomised pharmacoeconomic evaluation of patients with chronic schizophrenia exhibiting acute psychosis","volume":"7","author":"Lamure","year":"2003","journal-title":"International Journal of Psychiatry in Clinical Practice"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1192\/pb.20.3.149","article-title":"Rapid tranquillisation: a questionnaire survey of practice","volume":"20","author":"Simpson","year":"1996","journal-title":"Psychiatric Bulletin"},{"issue":"7","key":"10.1002\/14651858.CD000525.pub4-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1192\/pb.21.7.411","article-title":"Rapid tranquillisation: are we getting it right?","volume":"21","author":"Mannion","year":"1997","journal-title":"Psychiatric Bulletin"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0026|cit26","unstructured":"Higgins JP Lasserson T Thomas J Flemyng E Churchill R Methodological expectations of Cochrane intervention reviews. Cochrane: London, Version August 2023 Available from https:\/\/community.cochrane.org\/mecir-manual"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0028|cit28","doi-asserted-by":"publisher","volume-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-5.","year":"2013","DOI":"10.1176\/appi.books.9780890425596"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0029|cit29","volume-title":"The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines.","author":"World Health Organization","year":"1992"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0030|cit30","volume-title":"Structured Clinical Interview for DSM-5 Disorders\u2014Clinician Version (SCID-5-CV)","author":"First","year":"2016"},{"issue":"4","key":"10.1002\/14651858.CD000525.pub4-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"209","DOI":"10.15171\/bi.2017.25","article-title":"Study-based registers of randomized controlled trials: starting a systematic review with data extraction or meta-analysis","volume":"7","author":"Shokraneh","year":"2017","journal-title":"BioImpacts"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13643-019-1035-3","article-title":"Study-based registers reduce waste in systematic reviewing: discussion and case report","volume":"8","author":"Shokraneh","year":"2019","journal-title":"Systematic Reviews"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/9781119536604.ch4","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Lefebvre","year":"2019"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1136\/bmj.315.7112.884","article-title":"Mental health emergencies","volume":"315","author":"Coutinho","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0035|cit35","unstructured":"Review Manager (RevMan) The Cochrane Collaboration 2026"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1192\/bjp.176.3.249","article-title":"Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia","volume":"176","author":"Marshall","year":"2000","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0037|cit37","doi-asserted-by":"crossref","DOI":"10.1002\/9781119536604","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","volume":"2nd","author":"Higgins","year":"2019"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0038|cit38","unstructured":"Higgins JPT Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/archive\/v5.1.0"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0039|cit39","first-page":"1200","article-title":"Detecting skewness from summary information","volume":"31","author":"Altman","year":"1996","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The Brief Psychiatric Rating Scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychological Reports"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0041|cit41","volume-title":"Positive and Negative Syndrome Scale (PANSS) Manual","author":"Kay","year":"1986"},{"issue":"2-3","key":"10.1002\/14651858.CD000525.pub4-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.schres.2005.04.008","article-title":"What does the PANSS mean?","volume":"79","author":"Leucht","year":"2005","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1192\/bjp.187.4.366","article-title":"Clinical implications of brief psychiatric rating scale scores","volume":"187","author":"Leucht","year":"2005","journal-title":"British Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD000525.pub4-BIB0044|cit44","first-page":"405","article-title":"The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use","volume":"54","author":"Boissel","year":"1999","journal-title":"Therapie"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0045|cit45","unstructured":"Deeks J Issues in the selection for meta-analyses of binary data Proceedings of the 8th International Cochrane Colloquium; 2000 Oct 25-28; Cape Town Cape Town The Cochrane Collaboration 2000"},{"issue":"6","key":"10.1002\/14651858.CD000525.pub4-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/BF02599201","article-title":"The unit of analysis error in studies about physicians' patient care behavior","volume":"7","author":"Divine","year":"1992","journal-title":"Journal of General Internal Medicine"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/bmj.315.7108.600","article-title":"Statistics notes. Trials randomised in clusters","volume":"315","author":"Bland","year":"1997","journal-title":"BMJ"},{"issue":"9","key":"10.1002\/14651858.CD000525.pub4-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/oxfordjournals.aje.a009904","article-title":"Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: Data from the Health Survey for England 1994","volume":"149","author":"Gulliford","year":"1999","journal-title":"American Journal of Epidemiology"},{"issue":"19","key":"10.1002\/14651858.CD000525.pub4-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1002\/sim.1301","article-title":"Issues in the meta-analysis of cluster randomized trials","volume":"21","author":"Donner","year":"2002","journal-title":"Statistics in Medicine"},{"issue":"5","key":"10.1002\/14651858.CD000525.pub4-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"iii","DOI":"10.3310\/hta3050","article-title":"Methods for evaluating area-wide and organisation-based intervention in health and health care: A systematic review","volume":"3","author":"Ukoumunne","year":"1999","journal-title":"Health Technology Assessment"},{"issue":"1","key":"10.1002\/14651858.CD000525.pub4-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0052|cit52","unstructured":"Higgins JP Li T Deeks JJ Chapter 6: Choosing effect measures and computing estimates of effect. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/cochrane.org\/handbook"},{"issue":"7","key":"10.1002\/14651858.CD000525.pub4-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1192\/pb.bp.108.021949","article-title":"Loss to outcomes stakeholder survey: the LOSS study","volume":"33","author":"Xia","year":"2009","journal-title":"Psychiatric Bulletin"},{"issue":"1","key":"10.1002\/14651858.CD000525.pub4-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jclinepi.2005.06.006","article-title":"Imputing missing standard deviations in meta-analyses can provide accurate results","volume":"59","author":"Furukawa","year":"2006","journal-title":"Journal of Clinical Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD000525.pub4-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/schbul\/sbl025","article-title":"Is the superior efficacy of new generation antipsychotics an artifact of LOCF?","volume":"33","author":"Leucht","year":"2007","journal-title":"Schizophrenia Bulletin"},{"issue":"7109","key":"10.1002\/14651858.CD000525.pub4-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/9780470712184.ch12","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Sch\u00fcnemann","year":"2008"},{"issue":"1","key":"10.1002\/14651858.CD000525.pub4-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/(SICI)1099-1077(199801)13:1<17::AID-HUP937>3.0.CO;2-G","article-title":"A randomized controlled double blind study of zuclopenthixol acetate compared to haloperidol in acute psychosis","volume":"13","author":"Brook","year":"1998","journal-title":"Human Psychopharmacology: Clinical and Experimental"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0060|cit60","unstructured":"Ropert R Hoepfner Petersen HE Benyay J Where zuclopenthixol acetate stands amid the 'modified release' neuroleptics Congres de Psychiatrie et de Neurologie de Langue Francaise, LXXXVIth Session; 1988 Jun 13-17; Chambery, France 1988 350 62"},{"issue":"4","key":"10.1002\/14651858.CD000525.pub4-BIB0061|cit61","first-page":"202","article-title":"Observation of clinical effect of clopixol acuphase injection for acute psychosis","volume":"6","author":"Liu","year":"1997","journal-title":"Chinese Journal of Pharmaco Epidemiology"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0062|cit62","unstructured":"Rapid tranquilization of violent or agitated patients in a psychiatric emergency setting: pragmatic, randomized, allocation concealed, participant and assessor blinded trial of intramuscular zuclopenthixol acetate versus intramuscular haloperidol plus promethazine https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=CTRI\/2014\/07\/004712"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0063|cit63","unstructured":"Data Personal Communication 2015"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0064|cit64","unstructured":"Mythri SV Rapid tranquillisation of violent or agitated patients in a psychiatric emergency setting: pragmatic, randomized, allocation concealed, participant and assessor blinded, clinical trial of intramuscular zuclopenthixol acetate versus intramuscular combination of haloperidol plus promethazine Christian Medical College 2015 174"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0065|cit65","unstructured":"Final Report Personal Communication 2015"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0066|cit66","unstructured":"Mythri SV Tharyan P Sunder S Kattula D Kirubakaran R Adams CE Rapid tranquillization of violent or agitated patients in a psychiatric emergency setting: pragmatic, randomized, allocation concealed, participant and assessor blinded trial of intramuscular zuclopenthixol acetate versus intramuscular haloperidol plus promethazine Protocol 2013"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0067|cit67","first-page":"44","article-title":"Zuclopenthixol versus haloperidol in the initial treatment of schizophrenic psychoses, affective psychoses and paranoid states; a controlled clinical trial","volume":"7 (1)","year":"1996","journal-title":"Arab Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0068|cit68","first-page":"44","article-title":"Zuclopenthixol versus haloperidol in the initial treatment of schizophrenic psychoses, affective psychoses and paranoid states; a controlled clinical trial","volume":"7","author":"Al-Haddad","year":"1996","journal-title":"Arab Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00004714-199412000-00002","article-title":"A double-blind controlled study of intramuscular zuclopenthixol acetate and liquid oral haloperidol in the treatment of schizophrenic patients with acute exacerbation","volume":"14","author":"Chouinard","year":"1994","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0070|cit70","first-page":"35","volume-title":"Modern Trends in the Treatment of Chronic Schizophrenia","author":"Chouinard","year":"1991"},{"issue":"4","key":"10.1002\/14651858.CD000525.pub4-BIB0071|cit71","first-page":"365","article-title":"A double blind comparison of zuclopenthixol acetate with haloperidol in the management of acutely disturbed schizophrenics","volume":"53","author":"Chin","year":"1998","journal-title":"Medical Journal of Malaysia"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1600-0447.1993.tb03329.x","article-title":"A controlled Nordic multicentre study of zuclopenthixol acetate in oil solution, haloperidol and zuclopenthixol in the treatment of acute psychosis","volume":"87","author":"Baastrup","year":"1993","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3109\/08039489009096565","article-title":"Zuclopenthixol acetate, haloperidol, and zuclopenthixol in the treatment of acutely psychotic patients - a controlled multicentre study","volume":"44","author":"Fensbo","year":"1990","journal-title":"Nordisk Psykiatrisk Tidsskrift"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0074|cit74","unstructured":"Uys H Berk M A controlled double blind study of zuclopenthixol acetate compared with clothiapine in acute psychosis including mania and exacerbation of chronic psychosis Proceedings of XXth Collegium Internationale Neuro-psychopharmacologicum, Melbourne, Australia"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0075|cit75","first-page":"4","article-title":"A controlled double blind study of zuclopenthixol acetate compared to clothiapine in acute psychosis including mania and exacerbation of chronic psychosis","volume":"4","author":"Uys","year":"2001","journal-title":"Journal of Depression and Anxiety"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0076|cit76","first-page":"1301","article-title":"Comparative study of the effectiveness of zuclopenthixol acetate and haloperidol in acutely disturbed psychotic patients","volume":"85","author":"Taymeeyapradit","year":"2002","journal-title":"Journal of the Medical Association of Thailand"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0077|cit77","volume-title":"Early clinical drug evaluation (ECDEU) assessment manual for psychopharmacology. National Institute of Mental Health Publication No.76-338","author":"Guy","year":"1976"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/1097-4679(196501)21:1<65::AID-JCLP2270210122>3.0.CO;2-I","article-title":"The Nurses Observation Scale for Inpatient Evaluation (NOSIE): a new scale for measuring improvement in chronic schizophrenia","volume":"21","author":"Honingfeld","year":"1965","journal-title":"Journal of Clinical Psychology"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0079|cit79","first-page":"233","article-title":"Extrapyramidal symptom rating scale","volume":"7","author":"Chouninard","year":"1980","journal-title":"Canadian Journal of Neurological Science"},{"issue":"Suppl 334","key":"10.1002\/14651858.CD000525.pub4-BIB0080|cit80","first-page":"100","article-title":"The UKU side effects rating scale. A new comprehensive rating scale for psychotropic drugs and a cross sectional study of side effects in neuroleptic treated patients","volume":"76","author":"Lingjaerde","year":"1987","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1600-0447.1979.tb04484.x","article-title":"The Bech-Rafaelsen Mania Scale and the Hamilton Depression Scale: Evaluation of homogeneity and inter-observer reliability","volume":"59","author":"Bech","year":"1979","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0082|cit82","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x.","article-title":"A rating scale for extrapyramidal side effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatrica Scandinavica Supplementum"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0083|cit83","unstructured":"Bobon D De Bleeker E Zuclopenthixol acetate and haloperidol in acute psychotic patients. A randomized multicentre study Poster, European College of Neuropsychopharmocology Congress, Gothenburg"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0084|cit84","first-page":"47","volume-title":"New strategies in the treatment of aggressive, acutely psychotic patients","author":"Bobon","year":"1990"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0085|cit85","first-page":"236","article-title":"Zuclopenthixol acetate and haloperidol in acute psychoses - results of the AMDP subgroup of a Belgian multicentre study","volume":"87","author":"Bourdouxhe","year":"1987","journal-title":"Acta Psychiatrica Belgica"},{"issue":"1","key":"10.1002\/14651858.CD000525.pub4-BIB0086|cit86","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002304.pub2","article-title":"Clotiapine for acute psychotic illnesses","author":"Carpenter","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0087|cit87","volume-title":"Methods Guide for Effectiveness and Comparative Effectiveness Reviews [Internet]","author":"Chou","year":"2008"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0920-9964(99)00226-1","article-title":"Zuclopenthixol acetate in psychiatric emergencies: looking for evidence from clinical trials","volume":"46","author":"Coutinho","year":"2000","journal-title":"Schizophrenia Research"},{"issue":"3","key":"10.1002\/14651858.CD000525.pub4-BIB0089|cit89","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000525","article-title":"Zuclopenthixol acetate in the treatment of acute schizophrenia and similar serious mental illnesses","author":"Fenton","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD000525.pub4-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.1996.03540080059030","article-title":"Improving the quality of randomized controlled trials. The CONSORT statement","volume":"276","author":"Begg","year":"1996","journal-title":"JAMA"},{"issue":"15","key":"10.1002\/14651858.CD000525.pub4-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1001\/jama.285.15.1987","article-title":"The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials","volume":"285","author":"Moher","year":"2001","journal-title":"JAMA"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T00:06:23Z","timestamp":1794182783000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD000525.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":91,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd000525.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]}}}